Cingulate Other Current Liab from 2010 to 2024
| CING Stock | USD 4.36 0.16 3.81% |
Other Current Liabilities | First Reported 2010-12-31 | Previous Quarter 2 M | Current Value 1.2 M | Quarterly Volatility 609.2 K |
Check Cingulate financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cingulate's main balance sheet or income statement drivers, such as Depreciation And Amortization of 617.6 K, Interest Expense of 814.8 K or Selling General Administrative of 7.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Cingulate financial statements analysis is a perfect complement when working with Cingulate Valuation or Volatility modules.
Cingulate | Other Current Liab |
Latest Cingulate's Other Current Liab Growth Pattern
Below is the plot of the Other Current Liab of Cingulate over the last few years. It is Cingulate's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cingulate's overall financial position and show how it may be relating to other accounts over time.
| Other Current Liab | 10 Years Trend |
|
Other Current Liab |
| Timeline |
Cingulate Other Current Liab Regression Statistics
| Arithmetic Mean | 534,399 | |
| Geometric Mean | 309,800 | |
| Coefficient Of Variation | 113.99 | |
| Mean Deviation | 505,210 | |
| Median | 155,492 | |
| Standard Deviation | 609,186 | |
| Sample Variance | 371.1B | |
| Range | 1.9M | |
| R-Value | 0.76 | |
| Mean Square Error | 168.1B | |
| R-Squared | 0.58 | |
| Significance | 0.001 | |
| Slope | 103,695 | |
| Total Sum of Squares | 5.2T |
Cingulate Other Current Liab History
About Cingulate Financial Statements
Cingulate stakeholders use historical fundamental indicators, such as Cingulate's Other Current Liab, to determine how well the company is positioned to perform in the future. Although Cingulate investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cingulate's assets and liabilities are reflected in the revenues and expenses on Cingulate's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cingulate. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Current Liabilities | 2 M | 1.2 M |
Currently Active Assets on Macroaxis
When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:Check out the analysis of Cingulate Correlation against competitors. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (43.22) | Return On Assets (1.04) | Return On Equity (2.74) |
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.